Page last updated: 2024-08-18

pyrroles and Alopecia Areata

pyrroles has been researched along with Alopecia Areata in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	39 (58.21)	24.3611
2020's	28 (41.79)	2.80

Authors

Authors	Studies
AlAnazi, R; AlHarithy, R; AlHayaza, G; AlIssa, A; AlKhalifah, A; AlMarzoug, A; AlOrainy, M; AlSheikh, A; AlTawil, L	1
Dunnick, CA; Kibbie, J; Kines, K; Norris, D	1
Benton, S; Farah, R; Freese, R; Hordinsky, M	1
Albayda, J; Castillo, R	1
Agarwal, I; Das, A; Panda, M	1
Bordone, LA; Fan, W; Lavian, J; Lee, EY; Youssef, S	1
Arias-Santiago, S; Cantudo-Cuenca, MR; Diaz-Calvillo, P; Molina-Leyva, A; Rodriguez-Pozo, JA; Sanchez-Diaz, M; Tercedor-Sánchez, J	1
Geng, SL; Gong, T; Ji, C; Su, HH	1
Abdulla, N; Al-Obaidli, A; Ali-Alam, M; Husein-ElAhmed, H; Steinhoff, M	1
Barough, MS; Behrangi, E; Goodarzi, A; Hejazi, P; Khoramdad, M; Koltapeh, MP	1
Kantor, J	1
Perche, P; Pichardo, R; Purvis, C	1
Abolghasemi, S; Mardani, M; Mohammadshahi, J; Teimourpour, R	1
Deng, S; Huang, J; Li, J; Liu, F; Liu, Y; Rao, S; Shi, W; Tang, Y	1
Feng, S; Guo, L; Jiang, X; Liu, Y; Sun, B	1
Akdogan, N; Atakan, N; Doğan, S; Ersoy-Evans, S	1
Bhoyrul, B; John, JM; Kerkemeyer, KLS; Sinclair, R	1
Chen, YC; Chen, YY; Lan, CE; Lin, SY; Yang, CC	1
Fukuyama, M; Hayashida, M; Hisamatsu, T; Kikuchi, O; Matsuura, M; Minowa, S; Mitsui, T; Miura, M; Miyoshi, J; Ohyama, M; Ozaki, R; Saito, D; Sakuraba, A; Tokunaga, S; Wada, H	1
Askin, O; Balci Ekmekci, O; Oba, MC; Serdaroglu, S	1
Maksimow, A; Stintzing, D; Wohlrab, J	1
Dincer, D; Kose Ozkan, C; Tanacan, E	1
Desai, S; LaChance, A; Lo, K; Nambudiri, VE; Villa-Ruiz, C; Vleugels, RA	1
Kamath, S	1
Castelo-Soccio, L; McKenzie, PL	1
Banerjee, A; Banfield, C; Chen, L; Cox, LA; Craiglow, B; Guttman-Yassky, E; King, B; Page, K; Pavel, AB; Peeva, E; Sinclair, R; Vincent, MS; Zhang, W; Zhu, L	1
Chang, Y; Chen, J; Christiano, AM; Dai, Z	1
Bhoyrul, B; Kerkemeyer, KLS; Sinclair, RD	1
Bokhari, L; Lai, VWY; Sinclair, R	1
Bayart, CB; Bergfeld, WF; Hogan, S; Ibrahim, O; Piliang, M	1
Bayart, CB; Brichta, L; Craiglow, BG; DeNiro, KL; Sidbury, R	1
Cho, S; Huh, CH; Kim, MW; Kwon, O; Lee, JS; Park, HS; Yoon, HS	1
Heyes, C; Robertson, SJ; Ross, G; Varigos, GA; Vu, M	1
Craiglow, BG; King, BA; Liu, LY	3
King, BA; Liu, LY	3
Kravvas, G; Runcie, H	1
Bitterman, A; Borbon, J; Cerise, J; Chen, JC; Christiano, AM; Clynes, R; Jabbari, A; Mackay-Wiggan, J; Sansaricq, F; Ulerio, G	1
Ergun, T; Salman, A; Sarac, G	1
Cho, S; Huh, CH; Kwon, O; Lee, JS; Park, HS; Yoon, HS	1
Castelo-Soccio, L; Putterman, E	1
Cheng, MW; Goh, C; Kehl, A; Worswick, S	1
Suchonwanit, P; Triyangkulsri, K	1
Brown, L; Skopit, S	1
Craiglow, BG; King, BA	1
Cho, S; Lee, JS; Park, HS; Yoon, HS	1
Christiano, AM; Clynes, R; Dai, Z; de Jong, A; Duvic, M; Hordinsky, M; Jabbari, A; Lee, D; Li, MM; Mackay-Wiggan, J; Norris, DA; Price, V; Xing, L	1
Abudu, M; Gordon, SC; Ko, JM; Rosmarin, D; Zancanaro, P	1
Almutairi, N; Hussain, NH; Nour, TM	1
Chen, CC; Dai, YX	1
Aşkın, Ö; Çelik, U; Engin, B; Erkan, E; Kutlubay, Z; Oba, Ç; Serdaroğlu, S	1
Santos, LDN; Shapiro, J	1
Kwon, O; Park, H; Yu, DA	1
Gilhar, A; Keren, A; Laufer Britva, R; Paus, R	1
Aguirre-Félix, ÓG; Bueno-Arias, GM; Morales-Miranda, AY; Tovar-Franco, R	1
Waldmann, TA	1
Cerise, JE; Christiano, AM; Clynes, R; de Jong, A; Jabbari, A; Mackay-Wiggan, J; Nguyen, N; Ulerio, G	1
Gerdes, S; Gläser, R; Mrowietz, U; Schröder, O	1
Cerise, JE; Chen, JC; Christiano, AM; Craiglow, BG; Jabbari, A; Kennedy Crispin, M; King, BA; Ko, JM; Li, S; Marinkovich, MP; Oro, AE; Shankar, G; Urban, JR; Winge, MC	1
Craiglow, BG; Dai, F; King, BA; Liu, LY	1
Ahmad Nasrollahi, S; Firooz, A; Hashemi, A; Nassiri Kashani, M; Samadi, A	1
Ceovic, R; Gulin, SJ; Kostovic, K; Mokos, ZB	1
Damsky, W; King, BA	1
Ramot, Y; Shreberk-Hassidim, R; Zlotogorski, A	1

Reviews

14 review(s) available for pyrroles and Alopecia Areata

Article	Year
Tofacitinib in paediatric dermatoses: a narrative review. Clinical and experimental dermatology, 2022, Volume: 47, Issue:7 Topics: Alopecia Areata; Child; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles	2022
Efficacy and safety of tofacitinib for treatment of alopecia areata in children: A systematic review and meta-analysis. Journal of cosmetic dermatology, 2022, Volume: 21, Issue:12 Topics: Alopecia Areata; Child; Humans; Piperidines; Pyrroles	2022
Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2020, Volume: 34, Issue:1 Topics: Alopecia Areata; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Risk Assessment	2020
Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents. The journal of investigative dermatology. Symposium proceedings, 2018, Volume: 19, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Algorithms; Alopecia Areata; Autoimmune Diseases; Clinical Trials as Topic; Female; Humans; Janus Kinase Inhibitors; Male; Piperidines; Pyrimidines; Pyrroles	2018
Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature. Dermatology online journal, 2017, Jul-15, Volume: 23, Issue:7 Topics: Alopecia Areata; Humans; Janus Kinase Inhibitors; Male; Piperidines; Psoriasis; Pyrimidines; Pyrroles; Treatment Failure; Young Adult	2017
Role of janus kinase inhibitors in the treatment of alopecia areata. Drug design, development and therapy, 2018, Volume: 12 Topics: Alopecia Areata; Animals; Humans; Janus Kinase Inhibitors; Janus Kinases; Piperidines; Pyrimidines; Pyrroles	2018
An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review. Journal of drugs in dermatology : JDD, 2018, Aug-01, Volume: 17, Issue:8 Topics: Alopecia Areata; Child; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Steroids; Treatment Outcome	2018
What's New in Hair Loss. Dermatologic clinics, 2019, Volume: 37, Issue:2 Topics: 5-alpha Reductase Inhibitors; Alopecia; Alopecia Areata; Azetidines; Humans; Janus Kinase Inhibitors; Nitriles; Piperidines; Platelet-Rich Plasma; Purines; Pyrazoles; Pyrimidines; Pyrroles; Retinoids; Sulfonamides	2019
Janus kinase inhibitors: An innovative treatment for alopecia areata. The Journal of dermatology, 2019, Volume: 46, Issue:8 Topics: Administration, Oral; Alopecia Areata; Azetidines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Janus Kinase Inhibitors; Janus Kinases; Middle Aged; Nitriles; Piperidines; Purines; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; Sulfonamides; T-Lymphocytes, Cytotoxic; Treatment Outcome	2019
The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders. The journal of investigative dermatology. Symposium proceedings, 2013, Volume: 16, Issue:1 Topics: Alopecia Areata; Animals; Antibodies, Monoclonal; Autoimmune Diseases; Humans; Interleukin-15; Leukemia-Lymphoma, Adult T-Cell; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptors, Interleukin-15; Signal Transduction	2013
Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature. The Journal of dermatological treatment, 2017, Volume: 28, Issue:6 Topics: Alopecia Areata; Azetidines; Dermatitis, Atopic; Humans; Janus Kinase Inhibitors; Janus Kinases; Nitriles; Piperidines; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Skin Diseases; Sulfonamides; Vitiligo	2017
Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology. Current medicinal chemistry, 2017, May-31, Volume: 24, Issue:11 Topics: Administration, Oral; Alopecia Areata; Dermatitis, Atopic; Humans; Janus Kinases; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Signal Transduction; Skin Diseases; Vitiligo	2017
JAK inhibitors in dermatology: The promise of a new drug class. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:4 Topics: Alopecia Areata; Anti-Inflammatory Agents; Azetidines; Clinical Trials as Topic; Dermatitis, Atopic; Dermatologic Agents; Humans; Janus Kinases; Molecular Targeted Therapy; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; Skin Diseases; Sulfonamides; Vitiligo	2017
Janus kinase inhibitors in dermatology: A systematic review. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:4 Topics: Alopecia Areata; Anti-Inflammatory Agents; Antineoplastic Agents; Azetidines; Dermatologic Agents; Drug Eruptions; Humans; Janus Kinases; Molecular Targeted Therapy; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Signal Transduction; Skin Diseases; Sulfonamides	2017

Trials

5 trial(s) available for pyrroles and Alopecia Areata

Article	Year
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results. Journal of the American Academy of Dermatology, 2021, Volume: 85, Issue:2 Topics: Adult; Alopecia Areata; Double-Blind Method; Female; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Time Factors; Treatment Outcome; Young Adult	2021
Sublingual tofacitinib for alopecia areata: a roll-over pilot clinical trial and analysis of pharmacokinetics. International journal of dermatology, 2021, Volume: 60, Issue:9 Topics: Alopecia Areata; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Treatment Outcome	2021
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis. The Journal of investigative dermatology, 2018, Volume: 138, Issue:7 Topics: Adult; Alopecia Areata; Autoimmune Diseases; Biopsy; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Hair Follicle; Humans; Janus Kinase Inhibitors; Janus Kinases; Male; Middle Aged; Nitriles; Photography; Pilot Projects; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Severity of Illness Index; Treatment Outcome; Young Adult	2018
Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib. Journal of drugs in dermatology : JDD, 2018, Jul-01, Volume: 17, Issue:7 Topics: Administration, Cutaneous; Administration, Oral; Adult; Alopecia Areata; Female; Follow-Up Studies; Hair Follicle; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Treatment Outcome; Young Adult	2018
Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study. Dermatology (Basel, Switzerland), 2019, Volume: 235, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Alopecia; Alopecia Areata; Female; Hair; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Time Factors; Young Adult	2019

Other Studies

48 other study(ies) available for pyrroles and Alopecia Areata

Article	Year
Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population. International journal of dermatology, 2022, Volume: 61, Issue:7 Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Saudi Arabia; Treatment Outcome	2022
Oral tofacitinib for the treatment of alopecia areata in pediatric patients. Pediatric dermatology, 2022, Volume: 39, Issue:1 Topics: Adolescent; Alopecia; Alopecia Areata; Child; Female; Humans; Male; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome	2022
Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review. Dermatologic therapy, 2022, Volume: 35, Issue:4 Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies	2022
Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib. Modern rheumatology case reports, 2022, 06-24, Volume: 6, Issue:2 Topics: Adult; Alopecia; Alopecia Areata; Dermatomyositis; Female; Humans; Interferons; Piperidines; Pyrimidines; Pyrroles	2022
Tofacitinib therapy for alopecia areata is not associated with adverse events during COVID-19 infection. Journal of the American Academy of Dermatology, 2023, Volume: 88, Issue:5 Topics: Alopecia; Alopecia Areata; COVID-19; Humans; Piperidines; Pyrroles	2023
Tofacitinib for Treatment of Alopecia Areata: Real-world Evidence and Factors Associated with Therapeutic Response. Acta dermato-venereologica, 2022, 06-15, Volume: 102 Topics: Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles	2022
Oral tofacitinib for successful treatment of refractory alopecia areata in preschool children. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:12 Topics: Alopecia; Alopecia Areata; Child, Preschool; Humans; Piperidines; Pyrimidines; Pyrroles	2022
Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population. Dermatologic therapy, 2022, Volume: 35, Issue:12 Topics: Adult; Alopecia; Alopecia Areata; Arabs; Child; Cohort Studies; Female; Humans; Male; Prospective Studies; Pyrroles	2022
This Month in JAAD International: December 2022: Topical management of vitiligo with Janus kinase inhibitors. Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:6 Topics: Administration, Topical; Alopecia Areata; Humans; Janus Kinase Inhibitors; Janus Kinases; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Vitiligo	2022
Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy. Journal of drugs in dermatology : JDD, 2022, Dec-01, Volume: 21, Issue:12 Topics: Alopecia Areata; Female; Humans; Pyrroles; Vitiligo	2022
Drug-induced liver injury due to tofacitinib: a case report. Journal of medical case reports, 2023, Mar-18, Volume: 17, Issue:1 Topics: Adolescent; Alopecia Areata; Chemical and Drug Induced Liver Injury; Female; Humans; Iran; Protein Kinase Inhibitors; Pyrroles	2023
Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study. Acta dermato-venereologica, 2023, Nov-13, Volume: 103 Topics: Alopecia Areata; Humans; Protein Kinase Inhibitors; Pyrroles; Retrospective Studies	2023
Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata. Dermatologic therapy, 2019, Volume: 32, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Alopecia; Alopecia Areata; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome; Young Adult	2019
Response of alopecia areata of the beard to oral tofacitinib. Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:5 Topics: Administration, Oral; Adult; Aged; Alopecia Areata; Cheek; Chin; Humans; Janus Kinases; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Scalp; Treatment Outcome; Young Adult	2020
Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen. European journal of dermatology : EJD, 2019, 12-01, Volume: 29, Issue:6 Topics: Adult; Alopecia Areata; Cost Savings; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index; Treatment Outcome; Young Adult	2019
Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata. Clinical journal of gastroenterology, 2020, Volume: 13, Issue:5 Topics: Adult; Alopecia Areata; Colitis, Ulcerative; Female; Humans; Infliximab; Male; Piperidines; Pyrimidines; Pyrroles; Young Adult	2020
Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy. Journal of cosmetic dermatology, 2021, Volume: 20, Issue:3 Topics: Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles	2021
[Alopecia areata with good response to tofacitinib]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2021, Volume: 72, Issue:6 Topics: Alopecia; Alopecia Areata; Female; Humans; Middle Aged; Piperidines; Pyrimidines; Pyrroles	2021
Efficacy of systemic minoxidil and tofacitinib combination in treatment-resistant alopecia universalis. Journal of cosmetic dermatology, 2021, Volume: 20, Issue:6 Topics: Alopecia; Alopecia Areata; Humans; Minoxidil; Piperidines; Pyrimidines; Pyrroles	2021
Challenges of securing insurance approval for oral tofacitinib for the treatment of alopecia areata: a multi-institution retrospective review. Archives of dermatological research, 2022, Volume: 314, Issue:5 Topics: Aged; Alopecia Areata; Humans; Insurance; Medicare; Piperidines; Pyrimidines; Pyrroles; Quality of Life; Retrospective Studies; United States	2022
Pediatric Game Changers∗: Oral tofacitinib for the treatment of alopecia areata in children. Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:6 Topics: Alopecia; Alopecia Areata; Child; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Alopecia areata flare patterns in children and young adults while on systemic tofacitinib. Journal of the American Academy of Dermatology, 2022, Volume: 86, Issue:3 Topics: Alopecia; Alopecia Areata; Child; Humans; Piperidines; Pyrimidines; Pyrroles; Young Adult	2022
Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata. JCI insight, 2021, 04-08, Volume: 6, Issue:7 Topics: Administration, Topical; Alopecia Areata; Animals; Azetidines; CD8-Positive T-Lymphocytes; Cytokines; Isonicotinic Acids; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Macrophages; Mice, Inbred C3H; Nitriles; NK Cell Lectin-Like Receptor Subfamily K; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Triazoles	2021
Topical tofacitinib for the treatment of alopecia areata affecting facial hair. The British journal of dermatology, 2021, Volume: 185, Issue:3 Topics: Administration, Topical; Alopecia; Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Treatment of Alopecia Areata With Tofacitinib. JAMA dermatology, 2017, 06-01, Volume: 153, Issue:6 Topics: Adult; Alopecia Areata; Female; Follow-Up Studies; Hair; Humans; Male; Middle Aged; Piperidines; Polyps; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Scalp; Treatment Outcome; Young Adult	2017
Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata. Journal of the American Academy of Dermatology, 2017, Volume: 77, Issue:1 Topics: Administration, Cutaneous; Adolescent; Alopecia Areata; Child, Preschool; Female; Humans; Janus Kinases; Male; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Skin Cream	2017
Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series. Journal of the American Academy of Dermatology, 2017, Volume: 77, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Alopecia Areata; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Republic of Korea; Retrospective Studies; Severity of Illness Index; Young Adult	2017
Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo. Clinical and experimental dermatology, 2017, Volume: 42, Issue:8 Topics: Adult; Alopecia Areata; Dermatitis, Atopic; Humans; Janus Kinase Inhibitors; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Th2 Cells; Treatment Outcome; Vitiligo	2017
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:2 Topics: Adult; Alopecia Areata; Female; Hair; Humans; Male; Middle Aged; Ointments; Pilot Projects; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Young Adult	2018
Successful treatment of moderate-to-severe alopecia areata improves health-related quality of life. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3 Topics: Adult; Alopecia Areata; Emotions; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Young Adult	2018
Reply to: "Tofacitinib for the treatment of severe alopecia areata and variants". Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:2 Topics: Alopecia Areata; Humans; Piperidines; Pyrimidines; Pyrroles	2018
Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib. The Journal of dermatological treatment, 2018, Volume: 29, Issue:8 Topics: Administration, Oral; Adult; Alopecia Areata; Female; Humans; Male; Middle Aged; Nail Diseases; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies	2018
Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:6 Topics: Administration, Topical; Adolescent; Alopecia; Alopecia Areata; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hair; Humans; Male; Pediatrics; Piperidines; Pyrimidines; Pyrroles; Sampling Studies; Treatment Outcome	2018
Tofacitinib for the treatment of alopecia areata in preadolescent children. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:2 Topics: Administration, Oral; Age Factors; Alopecia Areata; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Janus Kinase Inhibitors; Male; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Quality of Life; Risk Assessment; Sampling Studies; Treatment Outcome	2019
Ruxolitinib for the treatment of severe alopecia areata. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:2 Topics: Adolescent; Adult; Alopecia Areata; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hair; Humans; Male; Middle Aged; Nitriles; Patient Satisfaction; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Retrospective Studies; Sampling Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2019
Therapeutic synergy between contact dermatitis from a wig-fixing device and tofacitinib on alopecia areata. The Journal of dermatology, 2019, Volume: 46, Issue:4 Topics: Adult; Alopecia Areata; Dermatitis, Contact; Hair; Humans; Male; Piperidines; Pyrimidines; Pyrroles; Silicone Gels; Treatment Outcome	2019
High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata. JCI insight, 2018, 10-04, Volume: 3, Issue:19 Topics: Adolescent; Adult; Alopecia Areata; Animals; Autoimmune Diseases; CD8-Positive T-Lymphocytes; Disease Models, Animal; Female; Follow-Up Studies; Hair Follicle; High-Throughput Nucleotide Sequencing; Humans; Lymph Nodes; Male; Mice; Mice, Inbred C3H; Middle Aged; NK Cell Lectin-Like Receptor Subfamily K; Pilot Projects; Piperidines; Pyrimidines; Pyrroles; Receptors, Antigen, T-Cell; Scalp; Treatment Outcome; Young Adult	2018
Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:6 Topics: Administration, Topical; Adult; Alopecia Areata; Cohort Studies; Eyebrows; Eyelashes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Treatment Outcome; Young Adult	2019
Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:4 Topics: Adult; Alopecia Areata; Female; Humans; Janus Kinases; Middle Aged; Nitriles; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Recurrence; Withholding Treatment	2019
Tofacitinib therapy for children with severe alopecia areata. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4 Topics: Alopecia; Alopecia Areata; Child, Preschool; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Severity of Illness Index	2019
Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients. Dermatologic therapy, 2019, Volume: 32, Issue:3 Topics: Adolescent; Adult; Alopecia Areata; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Treatment Outcome; Young Adult	2019
Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata. The British journal of dermatology, 2020, Volume: 182, Issue:1 Topics: Alopecia Areata; Animals; Mice; Piperidines; Pyrimidines; Pyrroles; Thalidomide	2020
Tofacitinib as a treatment of alopecia areata in adolescents. Boletin medico del Hospital Infantil de Mexico, 2019, Volume: 76, Issue:4 Topics: Administration, Oral; Adolescent; Alopecia Areata; Female; Humans; Male; Mexico; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2019
Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers. Experimental dermatology, 2016, Volume: 25, Issue:8 Topics: Adult; Alopecia Areata; Biomarkers; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin	2016
Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman. Acta dermato-venereologica, 2017, 02-08, Volume: 97, Issue:2 Topics: Adolescent; Alopecia; Alopecia Areata; Arthritis, Psoriatic; Female; Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retreatment	2017
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI insight, 2016, 09-22, Volume: 1, Issue:15 Topics: Adult; Aged; Alopecia Areata; Female; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; United States; Young Adult	2016
Tofacitinib for the treatment of alopecia areata and variants in adolescents. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:1 Topics: Adolescent; Alopecia; Alopecia Areata; Female; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2017
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:1 Topics: Adolescent; Adult; Aged; Alopecia; Alopecia Areata; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2017